Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumors Lymphomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03213704
What this trial is testing

Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+30 more
National Cancer Institute (NCI) 9
Early research (Phase 1)Study completedNCT04977167
What this trial is testing

Clinical Trial of HG146 Administered to Subjects With Advanced Solid Tumors or Lymphoma

Who this might be right for
Solid TumorLymphoma
HitGen Inc. 24
Early research (Phase 1)Study completedNCT00788099
What this trial is testing

Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid TumorsLymphomas
PharmaMar 45
Early research (Phase 1)Study completedNCT00769288
What this trial is testing

FAU in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+57 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Ended earlyNCT03422679
What this trial is testing

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Who this might be right for
Breast CancerColorectal CancerAdenoid Cystic Carcinoma+5 more
Cellestia Biotech AG 79
Testing effectiveness (Phase 2)Looking for participantsNCT03556228
What this trial is testing

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Who this might be right for
Head and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more
VM Oncology, LLC 242
Early research (Phase 1)Study completedNCT04728334
What this trial is testing

Dose Escalation and Expansion Study of AK117

Who this might be right for
Neoplasms Malignant
Akeso 49
Testing effectiveness (Phase 2)Study completedNCT03213665
What this trial is testing

Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Non-Hodgkin Lymphoma+38 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT06172894
What this trial is testing

PBMC-based Leukocyte Immunotherapy

Who this might be right for
Advanced Solid Tumor
invIOs GmbH 10
Early research (Phase 1)UnknownNCT02836834
What this trial is testing

Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors

Who this might be right for
LymphomaLung Cancer
Shanghai Junshi Bioscience Co., Ltd. 33
Early research (Phase 1)WithdrawnNCT03575078
What this trial is testing

ARQ761 + PARP Inhibitor in Refractory Solid Tumors

Who this might be right for
Lymphoma
University of Texas Southwestern Medical Center
Early research (Phase 1)Study completedNCT00779584
What this trial is testing

A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248)

Who this might be right for
Hodgkin DiseaseLymphoma, Non-HodgkinNeoplasms
Merck Sharp & Dohme LLC 45
Early research (Phase 1)Ended earlyNCT00558727
What this trial is testing

Study of RH-1 in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Advanced Solid TumorsNon-Hodgkin's Lymphoma
Spectrum Pharmaceuticals, Inc 12
Testing effectiveness (Phase 2)Study completedNCT03233204
What this trial is testing

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+33 more
National Cancer Institute (NCI) 6
Early research (Phase 1)Study completedNCT01588678
What this trial is testing

A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid TumorLymphoma
Daiichi Sankyo 32
Early research (Phase 1)Study completedNCT00348985
What this trial is testing

PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+58 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Looking for participantsNCT04752826
What this trial is testing

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

Who this might be right for
Advanced MalignanciesOvarian CancerT-cell Lymphoma+1 more
BioInvent International AB 250
Early research (Phase 1)UnknownNCT05374226
What this trial is testing

Evaluate JS019 in Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid Tumors or Lymphomas
Suzhou Kebo Ruijun Biotechnology Co., Ltd 172
Early research (Phase 1)Temporarily pausedNCT05279300
What this trial is testing

CS5001 in Patients With Advanced Solid Tumors and Lymphomas

Who this might be right for
Advanced Solid TumorAdvanced Lymphoma
CStone Pharmaceuticals 480
Early research (Phase 1)Study completedNCT01345357
What this trial is testing

Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma

Who this might be right for
Solid Tumors or Mantle Cell Lymphoma
Cephalon 24
Next Page